This likely reflects the fact that, in some pathologies, such as lung cancer, inhibition of the Nrf2 pathway could be beneficial, as it could reduce the aggressiveness of the tumor and/or increase its responsiveness to standard chemotherapy [53,54,55]. Here, NFE2L2 is linked to neoplasm.